Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Times Interest Earned (2016 - 2025)

China Pharma Holdings' Times Interest Earned history spans 16 years, with the latest figure at -$174.47 for Q4 2025.

  • For Q4 2025, Times Interest Earned rose 0.78% year-over-year to -$174.47; the TTM value through Dec 2025 reached -$118.9, up 29.13%, while the annual FY2025 figure was -$118.77, 29.2% up from the prior year.
  • Times Interest Earned reached -$174.47 in Q4 2025 per CPHI's latest filing, down from -$92.4 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $5.56 in Q4 2021 to a low of -$225.1 in Q3 2021.
  • Average Times Interest Earned over 5 years is -$95.29, with a median of -$99.49 recorded in 2023.
  • Peak YoY movement for Times Interest Earned: soared 97.59% in 2023, then tumbled 6026.77% in 2024.
  • A 5-year view of Times Interest Earned shows it stood at $5.56 in 2021, then plummeted by 203.45% to -$5.75 in 2022, then surged by 45.12% to -$3.16 in 2023, then crashed by 5472.43% to -$175.84 in 2024, then grew by 0.78% to -$174.47 in 2025.
  • Per Business Quant, the three most recent readings for CPHI's Times Interest Earned are -$174.47 (Q4 2025), -$92.4 (Q3 2025), and -$96.2 (Q2 2025).